These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3132384)

  • 1. Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):71-3. PubMed ID: 3132384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative in vitro activity of A-56268 against respiratory tract pathogens.
    Jansson L; Kalin M
    Eur J Clin Microbiol; 1987 Aug; 6(4):494-6. PubMed ID: 2959474
    [No Abstract]   [Full Text] [Related]  

  • 4. The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci.
    Dunkin KT; Jones S; Howard AJ
    J Antimicrob Chemother; 1988 Apr; 21(4):405-11. PubMed ID: 2837451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
    Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
    Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of moxifloxacin against respiratory pathogens in Latin America].
    López H; Sader H; Amábile C; Pedreira W; Muñoz Bellido JL; García Rodríguez JA;
    Rev Esp Quimioter; 2002 Dec; 15(4):325-34. PubMed ID: 12587037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
    Schmitz FJ; Schwarz S; Milatovic D; Verhoef J; Fluit AC
    J Antimicrob Chemother; 2002 Jul; 50(1):145-8. PubMed ID: 12096026
    [No Abstract]   [Full Text] [Related]  

  • 10. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004.
    Melo-Cristino J; Santos L; Ramirez M;
    Rev Port Pneumol; 2006; 12(1):9-30. PubMed ID: 16572254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
    Beekmann SE; Heilmann KP; Richter SS; García-de-Lomas J; Doern GV;
    Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens.
    Forsgren A; Walder M
    APMIS; 1994 Mar; 102(3):227-35. PubMed ID: 8185890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clarithromycin sensitivity survey in the United Kingdom using Stokes' method.
    Humphreys JE; Smith EG; Coles SJ
    J Antimicrob Chemother; 1993 Aug; 32(2):341-2. PubMed ID: 8226438
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro potency of nine orally administered antimicrobial agents against three respiratory tract pathogens.
    Barry AL
    Eur J Clin Microbiol Infect Dis; 1992 Sep; 11(9):867-9. PubMed ID: 1468431
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of tosufloxacin (A-60969) and clarithromycin (A-56268, TE-031) against resistant Haemophilus influenzae, Streptococcus pneumoniae and Branhamella catarrhalis isolates.
    Bryan JP; Waters C; Sheffield J; Wagner KF
    Eur J Clin Microbiol Infect Dis; 1990 May; 9(5):361-5. PubMed ID: 2142647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activity of CP-99219, a new quinolone, against respiratory pathogens.
    Sefton AM; Maskell JP; Seymour AC; Minassian M; Williams JD
    J Antimicrob Chemother; 1996 Apr; 37(4):803-8. PubMed ID: 8722546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C; Milatovic D; Braveny I
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies.
    Low DE; Brown S; Felmingham D
    Clin Microbiol Infect; 2004 Jan; 10(1):27-36. PubMed ID: 14706083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.